EG vs LXEO · P/E 17, rev $8.03B vs $147.7M cap
Everest Group Ltd (EG) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
LXEO does not have a complete income-statement cache yet.
EG currently screens at market cap $14.52B and trailing P/E 17.2. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the EG and LXEO stock pages for the full models.
Not investment advice.